R. Shaw

Molecular Biology · Molecules and Cells · 2004–2017

A researcher in the Science corpus: 16 papers; trusts 56 researchers and is trusted by 28 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 419 citations into it; #1,669 of 17,773 by trust here, #1,117 by citations
Epidemiology — 201 citations into it; #1,145 of 2,148 by trust here, #604 by citations
Physiology — 163 citations into it
Surgery — 118 citations into it; #732 of 1,106 by trust here, #277 by citations
Cell Biology — 91 citations into it; #1,015 of 2,073 by trust here, #292 by citations
Geriatrics and Gerontology — 36 citations into it
Endocrinology, Diabetes and Metabolism — 34 citations into it
Oncology — 34 citations into it

Whom R. Shaw trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts R. Shaw overall

Papers from R. Shaw's perspective

Ordered by how strongly the researchers R. Shaw trusts endorse each paper. Same corpus, a different order for every researcher.

TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
TOR signaling in growth and metabolism. (Cell)
Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. (Genes & Development)
mTOR and cancer: insights into a complex relationship (Nature Reviews. Cancer)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. (Molecules and Cells)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. (Molecules and Cells)
Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases (Proceedings of the National Academy of Sciences of the United States of America)
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)

Their papers

AMPK phosphorylation of raptor mediates a metabolic checkpoint. (2008) — 3,890 citations
The LKB1 tumor suppressor negatively regulates mTOR signaling. (2004) — 1,144 citations
Ras, PI(3)K and mTOR signalling controls tumour cell growth (2006) — 2,120 citations
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin (2005) — 2,021 citations
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-induced Insulin Resistant Mice (2011) — 1,696 citations
The AMP-activated protein kinase (AMPK) signaling pathway coordinates cell growth, autophagy, & metabolism (2011) — 2,755 citations
The LKB1-AMPK pathway: metabolism and growth control in tumor suppression (2009) — 1,941 citations
LKB1 and AMPK control of mTOR signalling and growth (2009) — 646 citations
AMP-activated protein kinase mediates mitochondrial fission in response to energy stress (2016) — 990 citations
Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates (2015) — 658 citations
AMPK: guardian of metabolism and mitochondrial homeostasis (2017) — 3,547 citations
AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance (2017) — 1,776 citations
Guidelines for the use and interpretation of assays for monitoring autophagy (2012) — 4,856 citations
AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degradation (2009) — 927 citations
AMPK and PPARd Agonists Are Exercise Mimetics (2008) — 1,087 citations
Resveratrol improves health and survival of mice on a high-calorie diet (2006) — 4,383 citations